| D008297 |
Male |
|
Males |
|
| D011183 |
Postoperative Complications |
Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. |
Complication, Postoperative,Complications, Postoperative,Postoperative Complication |
|
| D003324 |
Coronary Artery Disease |
Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause. |
Arteriosclerosis, Coronary,Atherosclerosis, Coronary,Coronary Arteriosclerosis,Coronary Atherosclerosis,Left Main Coronary Artery Disease,Left Main Coronary Disease,Left Main Disease,Arterioscleroses, Coronary,Artery Disease, Coronary,Artery Diseases, Coronary,Atheroscleroses, Coronary,Coronary Arterioscleroses,Coronary Artery Diseases,Coronary Atheroscleroses,Left Main Diseases |
|
| D005260 |
Female |
|
Females |
|
| D006710 |
Homocysteine |
A thiol-containing amino acid formed by a demethylation of METHIONINE. |
2-amino-4-mercaptobutyric acid,Homocysteine, L-Isomer,2 amino 4 mercaptobutyric acid,Homocysteine, L Isomer,L-Isomer Homocysteine |
|
| D006801 |
Humans |
Members of the species Homo sapiens. |
Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man |
|
| D016027 |
Heart Transplantation |
The transference of a heart from one human or animal to another. |
Cardiac Transplantation,Grafting, Heart,Transplantation, Cardiac,Transplantation, Heart,Cardiac Transplantations,Graftings, Heart,Heart Grafting,Heart Graftings,Heart Transplantations,Transplantations, Cardiac,Transplantations, Heart |
|
| D017354 |
Point Mutation |
A mutation caused by the substitution of one nucleotide for another. This results in the DNA molecule having a change in a single base pair. |
Mutation, Point,Mutations, Point,Point Mutations |
|
| D042965 |
Methylenetetrahydrofolate Reductase (NADPH2) |
A flavoprotein amine oxidoreductase that catalyzes the reversible conversion of 5-methyltetrahydrofolate to 5,10-methylenetetrahydrofolate. This enzyme was formerly classified as EC 1.1.1.171. |
Methylene-THF Reductase (NADPH),5,10-Methylenetetrahydrofolate Reductase (NADPH),Methylene Tetrahydrofolate Reductase,Methylenetetrahydrofolate Reductase,Methylenetetrahydrofolate Reductase (NADPH),Tetrahydrofolate Reductase, Methylene |
|
| D020138 |
Hyperhomocysteinemia |
Condition in which the plasma levels of homocysteine and related metabolites are elevated (>13.9 μmol/l). Hyperhomocysteinemia can be familial or acquired. Development of the acquired hyperhomocysteinemia is mostly associated with vitamins B and/or folate deficiency (e.g., PERNICIOUS ANEMIA, vitamin malabsorption). Familial hyperhomocysteinemia often results in a more severe elevation of total homocysteine and excretion into the urine, resulting in HOMOCYSTINURIA. Hyperhomocysteinemia is a risk factor for cardiovascular and neurodegenerative diseases, osteoporotic fractures and complications during pregnancy. |
Hyperhomocysteinemias |
|